Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine [Phase 4]

View source ↗

Summary

Phase 4 results show safety and immunogenicity of a booster dose of GlaxoSmithKline's hepatitis B vaccine, Engerix-B. The study assesses the booster response in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-09-14